Novartis AG (CHIX:NOVNz)
CHF 87.96 -0.78 (-0.88%) Market Cap: 177.46 Bil Enterprise Value: 193.40 Bil PE Ratio: 11.84 PB Ratio: 4.80 GF Score: 56/100

Novartis AG at ASCO Investor Meeting (Virtual) Transcript

Jun 05, 2023 / 12:00AM GMT
Release Date Price: CHF85.53 (+0.97%)
Unidentified Company Representative

Please welcome from investor relations , Sloan Simpson.

Sloan Simpson
Novartis AG - Head of IR - North America

Hi, everyone. Thank you so much for joining us at the Novartis Investor event at ASCO 2023. Welcome to everyone in the room and also to those who are with us online. We realize it's quite late for those in Europe so really appreciate your being with us.

We are excited to share the Kisqali data from the Phase III NATALEE study in early breast cancer, talk a bit about the opportunity that we see there. But first, a couple of housekeeping notes.

So we'll have a presentation, obviously, followed by Q&A. We'll take questions from the room but the people online can also submit questions. We'll read them out for you here in the room. Please just make sure to wait for the mic and to say your name before asking your question. We will try to wrap up here the presentation and Q&A by about 8:15 so we can have our reception afterwards.

With us today, we have Shreeram Aradhye, who is the President

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot